Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3964918
Max Phase: Preclinical
Molecular Formula: C17H16Cl2N2OS
Molecular Weight: 367.30
Molecule Type: Small molecule
Associated Items:
ID: ALA3964918
Max Phase: Preclinical
Molecular Formula: C17H16Cl2N2OS
Molecular Weight: 367.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cccc2c1N(C(=O)CSc1ncc(Cl)cc1Cl)CCC2
Standard InChI: InChI=1S/C17H16Cl2N2OS/c1-11-4-2-5-12-6-3-7-21(16(11)12)15(22)10-23-17-14(19)8-13(18)9-20-17/h2,4-5,8-9H,3,6-7,10H2,1H3
Standard InChI Key: FLTBYMGWJOPCBI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 367.30 | Molecular Weight (Monoisotopic): 366.0360 | AlogP: 4.77 | #Rotatable Bonds: 3 |
Polar Surface Area: 33.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.65 | CX LogD: 4.65 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.73 | Np Likeness Score: -2.03 |
1. (2015) Compounds of modulating TRPV3 function, |
Source(1):